https://bioutah.org/after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als/2026-05-07T23:29:39ZBioUtahenAFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS2026-05-07T23:29:39ZBloghttps://bioutah.org/biomarin-presents-new-data-on-the-effect-of-long-term-treatment-with-voxzogo-vosoritide-on-arm-span-bone-health-and-growth-in-children-with-achondroplasia-at-the-pediatric-endocrine-society/2026-05-07T21:22:20ZBioUtahenBioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society's 2026 Annual Meeting2026-05-07T21:21:53ZBlog